Skip to content
Search

Latest Stories

Tony Matharu's Integrity International acquires two London landmarks

Both Atlas House and the Crescent will join the Blue Orchid Hospitality brand

Tony Matharu's Integrity International acquires two London landmarks

THE Integrity International Group, led by British Asian hotelier Tony Matharu, has acquired two properties in London - Atlas House and Crescent buildings for an undisclosed amount.

Atlas House, a Grade II-listed building, is situated at the junction of King Street, Queen Street, and Cheapside, while the Crescent is located adjacent to Tower Suites by Blue Orchid Hotels.


Both Atlas House and the Crescent will join the Blue Orchid Hospitality brand, part of Integrity, the group said in a statement.

Meanwhile, the company recently restructured its Garage Hotels Group, the statement said.

“The recent acquisition of Atlas House and the Crescent portfolio demonstrates our continued commitment to invest in and breathe new life into London property, particularly those buildings at the end of their previous lives, ensuring that London remains the best place to live, work, visit, and invest,” Matharu said.

“The team at Integrity International Group has unrivalled expertise in acquiring, developing and operating first-class hospitality facilities.”

The two properties will be added to the group’s portfolio, which includes luxury hotels, apartments, suites, residences, and venues, the statement said. These include the Westminster-based Wellington and Rochester hotels; Tower Suites and Tower Residences; as well as 55 Broadway, a Grade I-listed building set to be repurposed into a 526-room hotel in St James’s Park.

Prior to establishing Integrity International Group, Matharu was the founder of Grange Hotels which he ran as group managing director until its key London sites were sold to Jurys Inn (now Leonardo Hotels) in 2019, according to Integrity. Matharu has delivered over 2,500 hotel rooms and facilitated the creation of 1,750 jobs throughout London.

In January, Starwood Capital Group, a US-based private equity firm, acquired 10 Radisson Blu Edwardian properties in London, totaling 2,053 rooms, from Edwardian Hotels London, a UK hospitality group chaired by Jasminder Singh.

Matharu was ranked 23rd in the Asian Rich List 2023 published by Asian Media Group with an estimated wealth of £630 million.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less